Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schain

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 12, 2022
In vivo correlation of serotonin transporter and 1B receptor availability in the human brain: a PET studyJonas E Svensson, Mikael Tiger, Pontus Plavén-Sigray, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2012
Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRTMartin Schain, Miklós Tóth, Zsolt Cselényi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease PatientsIda Sonni, Patrik Fazio, Martin Schain, et al.
Neuroimage|January 10, 2012
Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systemsMartin Schain, Miklós Tóth, Zsolt Cselényi, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 21, 2021
Early stopping in clinical PET studies: How to reduce expense and exposureJonas E Svensson, Martin Schain, Gitte M Knudsen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 4, 2018
Regional times to equilibria and their impact on semi-quantification of [<sup>18</sup>F]AV-1451 uptakeKerstin Heurling, Ruben Smith, Olof T Strandberg, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 11, 2013
Arterial input function derived from pairwise correlations between PET-image voxelsMartin Schain, Simon Benjaminsson, Katarina Varnäs, et al.
Translational Psychiatry|May 11, 2021
Serotonin transporter availability increases in patients recovering from a depressive episodeJonas E Svensson, Cecilia Svanborg, Pontus Plavén-Sigray, et al.
Neuroimage|September 10, 2022
Designing drug occupancy studies with PET neuroimaging: Sample size, occupancy ranges and analytical methodsGjertrud Louise Laurell, Pontus Plavén-Sigray, Claus Svarer, et al.
Psychiatry and Clinical Neurosciences|January 17, 2020
[<sup>11</sup> C]raclopride positron emission tomography study of dopamine-D<sub>2/3</sub> receptor binding in patients with severe major depressive episodes before and after electroconvulsive therapy and compared to control subjectsMikael Tiger, Jonas Svensson, Benny Liberg, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 12, 2022
In vivo correlation of serotonin transporter and 1B receptor availability in the human brain: a PET studyJonas E Svensson, Mikael Tiger, Pontus Plavén-Sigray, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2012
Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRTMartin Schain, Miklós Tóth, Zsolt Cselényi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease PatientsIda Sonni, Patrik Fazio, Martin Schain, et al.
Neuroimage|January 10, 2012
Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systemsMartin Schain, Miklós Tóth, Zsolt Cselényi, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 21, 2021
Early stopping in clinical PET studies: How to reduce expense and exposureJonas E Svensson, Martin Schain, Gitte M Knudsen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 4, 2018
Regional times to equilibria and their impact on semi-quantification of [<sup>18</sup>F]AV-1451 uptakeKerstin Heurling, Ruben Smith, Olof T Strandberg, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 11, 2013
Arterial input function derived from pairwise correlations between PET-image voxelsMartin Schain, Simon Benjaminsson, Katarina Varnäs, et al.
Translational Psychiatry|May 11, 2021
Serotonin transporter availability increases in patients recovering from a depressive episodeJonas E Svensson, Cecilia Svanborg, Pontus Plavén-Sigray, et al.
Neuroimage|September 10, 2022
Designing drug occupancy studies with PET neuroimaging: Sample size, occupancy ranges and analytical methodsGjertrud Louise Laurell, Pontus Plavén-Sigray, Claus Svarer, et al.
Psychiatry and Clinical Neurosciences|January 17, 2020
[<sup>11</sup> C]raclopride positron emission tomography study of dopamine-D<sub>2/3</sub> receptor binding in patients with severe major depressive episodes before and after electroconvulsive therapy and compared to control subjectsMikael Tiger, Jonas Svensson, Benny Liberg, et al.
Pageof 5